| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/11/2010 | US7714018 Heterocyclic antiviral compounds |
| 05/11/2010 | US7713985 2-Phenyl-s-triazolo[4,3-c]quinazolin-3-one derivatives; neurodegenerative and central nervous system disorders; Parkinson's and Alzheimer's disease; restless leg syndrome; sleep, attention deficit, and psychological disorders; antidepressants; strokes, psychosis |
| 05/11/2010 | US7713964 Methods for treating asthmatic conditions |
| 05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
| 05/11/2010 | CA2415532C Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
| 05/06/2010 | WO2010050456A1 Piperidine compound having di- or tri-arylmethyl structure |
| 05/06/2010 | WO2010050445A1 Bicyclic compound |
| 05/06/2010 | WO2010049366A1 Tricyclic compounds as glutamate receptor modulators |
| 05/06/2010 | WO2010030538A3 Compounds for the treatment of hepatitis c |
| 05/06/2010 | WO2010012381A8 Streptospirole derivatives |
| 05/06/2010 | US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 |
| 05/06/2010 | US20100113418 Heterocyclic compound |
| 05/05/2010 | EP2181998A1 New benzothiazinone derivative and its use as antibacterial agent |
| 05/05/2010 | EP2181996A1 Aminopiperidine derivatives |
| 05/05/2010 | EP2181990A1 Piperidine derivative |
| 05/05/2010 | CN1960982B Method for separating 1,3-dioxolan-4,6-dione compound |
| 05/04/2010 | US7709643 Synthesis of sodium narcistatin and related compounds |
| 05/04/2010 | US7709497 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor |
| 05/04/2010 | US7709496 8-(2-{cis-4-[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-hydroxycyclohexyl}ethyl)-2H-chromen-2-one; may be formulated for administration in any convenient way; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 05/04/2010 | US7709477 Triheterocyclic Compounds; small cell lung cancer, follicular lymphoma, non-small cell lung cancer, non-Hodgkin's disease lymphoma, or acute myelocytic leukemia |
| 05/04/2010 | US7709475 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010046388A1 Substituted (aza) -1-methyl-1h-quinolin-2-ones as antibacterials |
| 04/29/2010 | WO2010045987A1 Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials |
| 04/29/2010 | US20100105913 Process for the preparation of tiotropium bromide |
| 04/29/2010 | US20100105895 Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof |
| 04/29/2010 | US20100105717 Tacrolimus for improved treatment of transplant patients |
| 04/29/2010 | US20100105673 Substituted aminofuranones and their use |
| 04/29/2010 | US20100105099 Tri-functionalized cryptophane, synthesis and uses thereof |
| 04/29/2010 | US20100104659 Benzopyranopyrazoles |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/28/2010 | EP2179999A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 04/28/2010 | EP2179996A1 Sulfonated diarylrhodamine dyes |
| 04/28/2010 | EP2178882A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 04/28/2010 | EP2178874A1 Heterocyclic compounds useful as mk2 inhibitors |
| 04/28/2010 | EP2178855A1 Process for the enantioselective preparation of pregabalin |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | CN1875020B Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
| 04/28/2010 | CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/28/2010 | CN1434043B Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 04/27/2010 | US7705012 7-iminomethyl or 7-oxymethyl camptothecin derivatives conjugated, possibly by means of suitable spacers, to cyclopeptide derivatives containing the arginine-glycine-aspartic acid sequence; anticarcinogenic, antimetastasis agent; high affinity for integrin receptors alpha v beta 3 and alpha v beta 5 |
| 04/27/2010 | US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
| 04/27/2010 | US7704996 Compounds and compositions useful as cathepsin S inhibitors |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 04/22/2010 | WO2010045551A1 Xanthenone-4-acetic acid derivatives |
| 04/22/2010 | WO2010045251A2 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | WO2010045197A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | WO2010044470A1 Π-electron conjugated compound, manufacturing method therefor, and π-electron conjugated polymer obtained using same |
| 04/22/2010 | WO2010043714A1 Tricyclic nitrogen compounds used as antibacterials |
| 04/22/2010 | WO2010043155A1 Novel purpurone-type alkaloids, process for their preparation, and their usage as medications |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2010003313A8 Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof |
| 04/22/2010 | US20100099874 Transannular rearrangement of activated lactams |
| 04/22/2010 | US20100099728 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | US20100099688 Novel phosphodiesterase inhibitors |
| 04/22/2010 | DE102008051690B3 Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten Process for the preparation of spirocyclic Tetronsäurederivaten |
| 04/22/2010 | CA2741029A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | CA2741024A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 04/21/2010 | EP2177223A2 Homoharringonine alone or combined with other agents for use in treating chronic myelogenous leukemia resistant or intolerant to sti571 |
| 04/21/2010 | EP2176267A1 Lanthanide (iii) ion complexing compounds, luminescent lanthanide (iii) ion complexes and use thereof as fluorescent labels |
| 04/21/2010 | EP2176251A2 5-pyridinone substituted indazoles |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN101696184A Iodine-phenyl-substituted cyclic cetoenols |
| 04/20/2010 | US7700773 cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 04/20/2010 | US7700641 Spiro-oxindole compounds and their uses as therapeutic agents |
| 04/20/2010 | US7700616 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 04/20/2010 | US7700613 Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms |
| 04/20/2010 | US7700612 improved bioavailability, reduced toxicity; anticancer agents |
| 04/20/2010 | US7700611 Synthesis and crystalline forms of NPY5 antagonist |
| 04/20/2010 | US7700609 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune disease; viricides |
| 04/20/2010 | CA2565411C Compounds and methods for inhibiting mitotic progression |
| 04/20/2010 | CA2435372C Process for purifying 20(s)-camptothecine |
| 04/20/2010 | CA2434370C Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith |
| 04/15/2010 | WO2010021680A3 Inhibitors of beta-secretase |
| 04/15/2010 | US20100093764 AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/15/2010 | US20100093763 PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/15/2010 | US20100093723 HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO[2,3 d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/15/2010 | US20100093705 Therapeutic agents, and methods of making and using the same |
| 04/15/2010 | US20100092887 FLUORINE-CONTAINING QUINACRIDONES IN COLOUR FILTERS FOR LCDs |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2173747A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| 04/14/2010 | CN101693714A spirocyclic cyclohexane derivatives |
| 04/13/2010 | US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
| 04/13/2010 | US7695980 Chemiluminescent compounds and their use |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/08/2010 | WO2010039789A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 04/08/2010 | WO2010039218A1 Method of purifying crude noscapine |
| 04/08/2010 | US20100087647 Processes for the production of buprenorphine with reduced impurity formation |
| 04/08/2010 | US20100087453 Compounds, screens, and methods of treatment |